Angiotensin II: A possible target for therapeutic intervention in COVID-19

• Mohammad Rafi Khezri,
• Keyvan Yousefi,
• Morteza Ghasemnejad-Berenji

Affiliations

Mohammad Rafi Khezri

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran; Corresponding author.

Keyvan Yousefi

Department of Molecular and Cellular Pharmacology, University of Miami-Miller School of Medicine, Miami, FL, USA

Morteza Ghasemnejad-Berenji

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran; Correspondence to: Department of Pharmacology, School of Pharmacy, Urmia University of Medical Sciences, Sero Road, Urmia, Iran.